Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Heart

• Publication date

  2004-08-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/hrt.2003.023069PMID 15310691PMCID PMC1768430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)

  2003cited by this paper
• Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.

  2003cited by this paper
• Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials

  2003cited by this paper
• Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study

  2002cited by this paper
• Factors associated with early atrial fibrillation after ablation of common atrial flutter. A single centre prospective study.

  2002cited by this paper
• Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling.

  2002cited by this paper
• Diuretic Therapy and Resistance in Congestive Heart Failure

  2002influential reference
• Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure

  2001cited by this paper
• Different Patterns of Angiotensin II and Atrial Natriuretic Peptide Secretion in a Sheep Model of Atrial Fibrillation

  2001cited by this paper
• Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.

  2000cited by this paper
• Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness.

  2000cited by this paper
• Right atrial angiographic evaluation of the posterior isthmus: relevance for ablation of typical atrial flutter.

  2000cited by this paper
• Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter.

  2000cited by this paper
• Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation.

  2000cited by this paper
• Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.

  2000cited by this paper
• Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation.

  1999cited by this paper
• Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

  1999cited by this paper
• Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.

  1999cited by this paper
• Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block.

  1999cited by this paper
• Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.

  1999cited by this paper
• Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study

  1998cited by this paper
• Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course.

  1998cited by this paper
• Long‐Term Outcome of Radiofrequency Catheter Ablation for Topical Atrial Flutter: Risk Prediction of Recurrent Arrhythmias

  1998cited by this paper
• Relation Between Left Atrial Size and Secondary Atrial Arrhythmias After Successful Catheter Ablation of Common Atrial Flutter

  1997cited by this paper
• Results of radiofrequency catheter ablation for atrial flutter.

  1996cited by this paper
• The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter.

  1995cited by this paper

• Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post‐Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest

  2025cites this paper
• Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest

  2025cites this paper
• Pathophysiology and clinical relevance of atrial myopathy

  2024cites this paper
• A Systematic Review and Meta-analysis of Renin-angiotensin Inhibitors and Angiotensin Receptor Neprilysin Inhibitors in Preventing Recurrence after Atrial Fibrillation Ablation.

  2023cites this paper
• Fluid Retention In The Pulmonary Circulation As A Cause Of Pulmonary Vein Dilatation And Atrial Fibrillation Development In Chronic Heart Failure Patients

  2022cites this paper
• Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation

  2022cites this paper
• World Cardiology

  2022cites this paper
• Prevention of Atrial Fibrillation After Atrial Flutter Ablation With Ramipril (from the PREFACE Study).

  2021cites this paper
• Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation

  2021cites this paper
• Factors associated with the efficacy of atrial fibrillation radiofrequency catheter ablation: opinion of the specialists who use the “ablation index” module

  2020cites this paper
• Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure

  2020cites this paper
• Renin-Angiotensin System Inhibitors for the Prevention of Atrial Fibrillation Recurrence After Ablation　- A Meta-Analysis.

  2020cites this paper
• [Atrial fibrillation].

  2020cites this paper
• Dual antithrombotic plus adjunctive antiinflammatory therapy to improve cardiovascular outcome in atrial fibrillation patients with concurrent acute coronary syndrome: A triple-pathway strategy.

  2018cites this paper
• Atrial fibrillation inducibility during cavo-tricuspid isthmus dependent atrial flutter ablation for the prediction of clinical atrial fibrillation.

  2017cites this paper
• Atrial fibrillation in highly trained endurance athletes - Description of a syndrome.

  2017cites this paper
• Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure

  2017cites this paper
• Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT.

  2017cites this paper
• Relationship between Angiotensin Converting Enzyme, Apelin, and New-Onset Atrial Fibrillation after Off-Pump Coronary Artery Bypass Grafting

  2017cites this paper
• Incidence of Atrial Fibrillation After Atrial Flutter Ablation.

  2016cites this paper
• Fitness and the development of atrial fibrillation.

  2015cites this paper
• Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction.

  2015cites this paper
• АМЕРИКАНСКОЙ КОЛЛЕГИИ АМЕРИКАНСКОЙ КАРДИОЛОГИ-ЧЕСКОЙ АССОЦИАЦИИ И ЕВРОПЕЙСКОГО ОБЩЕСТВА КАРДИОЛОГОВ (2006) ПО ВЕДЕНИЮ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ РЕКОМЕНДАЦИИ ПО ЛЕЧЕНИЮ

  2015cites this paper
• Impact of Impaired Renal Function on the Incidence of Atrial Fibrillation following Radiofrequency Ablation of Cavotricuspid Isthmus-Dependent Atrial Flutter

  2015cites this paper
• Renin-angiotensin system blockers in cardiac surgery.

  2015cites this paper
• Atrial Fibrillation in Athletes

  2015cites this paper
• HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter.

  2015cites this paper
• Prognostic value of atrial fibrillation inducibility after right atrial flutter ablation.

  2014cites this paper
• Effect of angiotensin II on STAT3 mediated atrial structural remodeling.

  2014cites this paper
• Prevalence and management of atrial fibrillation in middle-aged/older athletes

  2013cites this paper
• Arrhythmias in Athletes: Evidence-Based Strategies and Challenges for Diagnosis, Management, and Sports Eligibility

  2013cites this paper
• Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation.

  2013cites this paper
• Effect of Telmisartan and Ramipril on Atrial Fibrillation Recurrence and Severity in Hypertensive Patients With Metabolic Syndrome and Recurrent Symptomatic Paroxysmal and Persistent Atrial Fibrillation

  2012cites this paper
• Atrial fibrillation in athletes.

  2012cites this paper
• The role of the renin–angiotensin system blocking in the management of atrial fibrillation

  2012cites this paper
• Prevalence, mechanism and management of atrial fibrillation in athletes

  2011cites this paper
• Upstream Effect for Atrial Fibrillation: Still a Dilemma?

  2011cites this paper
• 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the Europe

  2011cites this paper
• Renin‐Angiotensin System Blocker Use May Be Associated with Suppression of Atrial Fibrillation Recurrence after Pulmonary Vein Isolation

  2011cites this paper
• 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2011cites this paper
• Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

  2011cites this paper
• eft atrial volume index as a predictor for ccurrence of atrial fibrillation after ablation of ypical atrial flutter

  2010cites this paper
• Is Endurance Sport a Risk Factor for atrial Fibrillation

  2010cites this paper
• Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter.

  2010cites this paper
• Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on the Long-Term Outcome after Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

  2010cites this paper
• Endurance Sport Practice and Atrial Fibrillation.

  2010cites this paper
• Reducing the Risk of Recurrences after Pulmonary Vein Isolation: What Is the Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers?

  2010cites this paper
• Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.

  2009cites this paper
• Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis

  2009cites this paper
• The Role of Inflammation in Atrial Fibrillation: A Myth or a Fact?

  2009cites this paper
• Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation

  2009cites this paper
• Left atrial remodeling in atrial fibrillation - mechanisms, assessment and therapeutic

  2009cites this paper
• Incidence of atrial fibrillation during very long-term follow-up after radiofrequency ablation of typical atrial flutter.

  2009cites this paper
• Acute success and short-term follow-up of catheter ablation of isthmus-dependent atrial flutter; a comparison of 8 mm tip radiofrequency and cryothermy catheters

  2008cites this paper
• Typical atrial flutter as a risk factor for the development of atrial fibrillation in patients without otherwise demonstrable atrial tachyarrhythmias.

  2008cites this paper
• Non-antiarrhythmic medications for atrial fibrillation: From bench to clinical practice

  2008cites this paper
• The role of the renin angiotensin system blocking in the management of atrial fibrillation

  2008cites this paper
• Upstream therapies to prevent atrial fibrillation

  2008cites this paper
• Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter

  2008cites this paper
• Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation.

  2008cites this paper
• Atrial Fibrillation and Flutter

  2007cites this paper
• Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model.

  2007cites this paper
• ARBs, ACE‐Is, or Statins After Catheter Ablation of Atrial Fibrillation?

  2007cites this paper
• Management of atrial fibrillation in patients with heart failure.

  2007cites this paper
• Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.

  2007cites this paper
• Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter.

  2006cites this paper
• Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers

  2006cites this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ

  2006cites this paper
• ACC/AHA/ESC: Guía de práctica clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida

  2006cites this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit

  2006cites this paper
• Long-term symptomatic benefit after radiofrequency catheter ablation for atrial flutter despite a high incidence of post-procedural atrial fibrillation

  2006cites this paper
• AB18-5: Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and statins: No effect on ablation outcome after ablation of atrial fibrillation

  2006cites this paper
• Clinical trials, the renin angiotensin system and atrial fibrillation

  2006cites this paper
• Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.

  2005cites this paper
• Rate versus rhythm control in the management of patients with atrial fibrillation

  2005cites this paper
• Severe Left Ventricular Systolic Dysfunction Increases Atrial Fibrillation After Ablation of Atrial Flutter

  2005cites this paper
• Inflammation in the genesis and perpetuation of atrial fibrillation.

  2005cites this paper
• Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?

  2005cites this paper
• World Journal of Cardiology

  year unknowncites this paper